Characterization of CA 19-9 bearing mucins as physiological exocrine pancreatic secretion products.

The monoclonal antibody CA 19-9 reacts with a carbohydrate epitope (sialylated lacto-N-fucopentaose II), which was shown to be part of a ganglioside extracted from a colon carcinoma cell line as well as of a mucin isolated from gastrointestinal tract tumor patients' sera. Recently, when we compared CA 19-9 levels in pancreatic juices and corresponding serum samples from a large group of patients, we showed the high serum values to be indicative solely for a malignant disease. In contrast, the overall high CA 19-9 content in pancreatic juices from all diagnostic groups raised the question about the antigenic moieties in these samples. By means of thin layer chromatography of glycolipids with subsequent antibody overlay, gel chromatography, and density gradient analysis, we found only the mucin form in all sources investigated. Thus we conclude that the discrimination potential of the CA 19-9 assay in serum is based on an altered secretion or distribution in pancreatic tumors.

[1]  M. Herlyn,et al.  Monoclonal antibody detection of a circulating tumor-associated antigen. II. A longitudinal evaluation of patients with colorectal cancer , 1982, Journal of Clinical Immunology.

[2]  H. Kern,et al.  Histological and fine structural features of pancreatic ductal adenocarcinomas in relation to growth and prognosis: studies in xenografted tumours and clinico‐histopathological correlation in a series of 75 cases , 1985, Histopathology.

[3]  N. Soehendra,et al.  Monoclonal antibody defines CA 19-9 in pancreatic juices and sera. , 1985, Gut.

[4]  F. Hanisch,et al.  Structure of tumor-associated carbohydrate antigen Ca 19-9 on human seminal-plasma glycoproteins from healthy donors. , 1984, European journal of biochemistry.

[5]  M. Herlyn,et al.  Immunodiagnosis of Human Solid Tumours , 1984 .

[6]  F. Hanisch,et al.  Unexpected occurrence of the Ca 19-9 tumor marker in normal human seminal plasma. , 1984, Hoppe-Seyler's Zeitschrift fur physiologische Chemie.

[7]  J. Magnani,et al.  Cancer-Associated Carbohydrate Antigens Detected by Monoclonal Antibodies , 1984 .

[8]  H. Koprowski,et al.  Identification of the gastrointestinal and pancreatic cancer-associated antigen detected by monoclonal antibody 19-9 in the sera of patients as a mucin. , 1983, Cancer research.

[9]  U. Ulmsten,et al.  Isolation and characterization of human cervical-mucus glycoproteins. , 1983, The Biochemical journal.

[10]  V. Zurawski,et al.  Radioimmunometric assay for a monoclonal antibody-defined tumor marker, CA 19-9. , 1983, Clinical chemistry.

[11]  M. Brockhaus,et al.  A monoclonal antibody-defined antigen associated with gastrointestinal cancer is a ganglioside containing sialylated lacto-N-fucopentaose II. , 1982, The Journal of biological chemistry.

[12]  M. Brockhaus,et al.  Monoclonal antibodies directed against the human Leb blood group antigen. , 1981, The Journal of biological chemistry.

[13]  M. Brockhaus,et al.  A monosialoganglioside is a monoclonal antibody-defined antigen of colon carcinoma. , 1981, Science.

[14]  T. Feizi.  Carbohydrate differentiation antigens , 1981 .

[15]  L. Svennerholm,et al.  A procedure for the quantitative isolation of brain gangliosides. , 1980, Biochimica et biophysica acta.

[16]  M. Herlyn,et al.  Colorectal carcinoma antigens detected by hybridoma antibodies , 1979, Somatic cell genetics.

[17]  A. Allen,et al.  Characterization of gastric mucoproteins isolated by equilibrium density-gradient centrifugation in caesium chloride. , 1974, The Biochemical journal.